UCI MEDICAL AFFILIATES INC
10QSB, 1996-04-26
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: UCI MEDICAL AFFILIATES INC, 8-K, 1996-04-26
Next: CANYON RESOURCES CORP, DEF 14A, 1996-04-26




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                   FORM 10-QSB

(Mark One)

( X )    QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE 
         ACT OF 1934

For the quarterly period ended:                      March 31, 1996

(  )     TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT

For the transition period from:                                to

Commission file number:                                       0-13265

                          UCI MEDICAL AFFILIATES, INC,
        (Exact name of small business issuer as specified in its charter)

<TABLE>
<CAPTION>
                  Delaware                                             59-2225346
<S>                                                       <C>   
 (State or other jurisdiction of incorporation           (IRS Employer Identification No.)
  or organization)
</TABLE>

                    6168 St. Andrews Road, Columbia, SC 29212
                    (Address of principal executive offices)

                                 (803) 772-8840
                           (Issuer's telephone number)


       (Former name, address or fiscal year, if changed since last report)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. ( X )YES ( ) NO


                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Check whether the  registrant  filed all  documents  and reports  required to be
filed by Section 12, 13, or 15(d) of the Exchange Act after the  distribution of
securities under a plan confirmed by a court. ( )YES ( ) NO


                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:

       4,291,553 shares of $.05 common stock outstanding at March 31, 1996

   Transitional Small Business Disclosure Format (check one): ( )YES ( X ) NO
                                       1
<PAGE>


                          UCI MEDICAL AFFILIATES, INC.

                                      INDEX
<TABLE>
<CAPTION>

                                                                                                   PAGE
                                                                                                 NUMBER
<S>                                                                                              <C>

PART I            FINANCIAL INFORMATION

                  Item 1   Financial Statements

                           Consolidated  Balance  Sheets  - March  31,  1996 and
                           September 30, 1995                                                          3

                           Consolidated   Statements  of   Operations   for  the
                           quarters and the six months ending March 31, 1996 and
                           March 31, 1995                                                              4

                           Consolidated  Statements  of Cash  Flows  for the six
                           months ending March 31, 1996 and March 31, 1995                             5

                           Notes to Consolidated Financial Statements                                    6

                  Item 2   Management's Discussion and Analysis of Financial
                           Condition and Results of Operations                                     7 - 9


PART II           OTHER INFORMATION

                  Items 1-6                                                                           10


SIGNATURES                                                                                            11


                                       2

<PAGE>



                          UCI Medical Affiliates, Inc.

                           Consolidated Balance Sheets

</TABLE>
<TABLE>
<CAPTION>

                                                                 MARCH 31, 1996              SEPTEMBER 30, 1995
                                                                 -----------------------     -----------------------
                                                                     (UNAUDITED)                   (AUDITED)
<S>                                                             <C>                          <C>    
ASSETS
Current assets
   Cash and cash equivalents                                     $      174,160              $         76,513
   Accounts receivable, less allowance for doubtful accounts
       of $934,519 and $608,792                                        3,064,385                    2,343,325
   Inventory                                                             267,356                      265,068
   Deferred taxes                                                        491,543                      491,543
   Prepaid expenses and other current assets                             419,567                      282,060
                                                                 -----------------------     -----------------------
Total current assets                                                  4,417,011              ----------------------
                                                                                                   3,458,509

Property and equipment, less accumulated depreciation of
   $1,710,946 and $1,529,999                                          3,051,091                    2,795,384
Deferred taxes                                                          120,639                      120,639
Excess of cost over fair value of assets acquired, less
   accumulated amortization of $1,009,075 and
   $869,271                                                           4,818,258                    3,578,371
Other assets                                                            282,054                      262,768
                                                                 -----------------------     -----------------------

Total Assets                                                       $ 12,689,053                $  10,215,671
                                                                =======================     =======================

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
   Current portion of long-term debt                              $   1,614,574               $    1,244,603
   Accounts payable                                                   1,009,289                    1,652,792
   Accrued salaries and payroll taxes                                   551,328                      498,791
   Other accrued liabilities                                            381,714             ----------------------
                                                                                                     445,362
                                                                 -----------------------     -----------------------
Total current liabilities                                             3,556,905                    3,841,548

Long-term debt, net of current portion                                3,116,696                    3,121,098
                                                                 -----------------------     -----------------------
Total Liabilities                                                     6,673,601                    6,962,646
                                                                 -----------------------     -----------------------

Commitments and contingencies

Stockholders' Equity
   Preferred stock, par value $.01 per share:
      Authorized shares - 10,000,000; none issued                             0                            0
   Common stock, par value $.05 per share:
      Authorized shares - 10,000,000
      Issued and outstanding- 4,291,553 and 3,508,164
         shares                                                         214,578                       175,408
   Paid-in capital                                                   12,129,979                      9,694,256
   Accumulated deficit                                               (6,329,105)                    (6,616,639)
                                                                 -----------------------     -----------------------
Total Stockholders' Equity                                            6,015,452                     3,253,025
                                                                 -----------------------     -----------------------

Total Liabilities and Stockholders' Equity                          $12,689,053                 $  10,215,671
                                                                 =======================     =======================
</TABLE>
                 See Notes to Consolidated Financial Statements.

                                       3
<PAGE>



                          UCI Medical Affiliates, Inc.

                      Consolidated Statements of Operations
                                   (unaudited)
<TABLE>
<CAPTION>
                                                              Three Months Ended March 31,   Six Months Ended March 31,
                                                                   1996                1995                  1996            1995
                                                            ---------------     ----------------     -----------------  ------------

<S>                                                           <C>                <C>                <C>                <C>         
Revenues                                                      $  5,909,220       $  4,453,805       $ 11,069,503       $  8,089,538
Operating costs                                                  5,346,241          4,845,651          9,999,069          8,506,453
                                                              ------------       ------------       ------------       ------------
Operating margin                                                   562,979          1,070,434           (416,915)
                                                                                                                           (391,846)

General and administrative expenses                                 43,841             62,237             46,829
                                                                                                                             16,165
Depreciation and amortization                                      229,258            170,609            433,815            232,293
                                                              ------------       ------------       ------------       ------------
Income (loss) from operations                                      289,880            574,382           (696,037)
                                                                                                                           (578,620)

Other income (expense)
   Interest expense, net of interest income                       (137,456)          (288,953)          (151,634)
                                                                                                                            (76,504)
   Gain (loss) on disposal of equipment                              2,105              6,902
                                                                                                             778                  0
                                                              ------------       ------------       ------------       ------------
Other income (expense)                                            (136,678)          (286,848)          (144,732)
                                                                                                                            (76,504)

Income (loss) before benefit (provision )for
   income taxes                                                    153,202            287,534           (840,769)
                                                                                                                           (655,124)
Benefit (provision )for income taxes
                                                                         0                  0                  0                  0
                                                              ------------       ------------       ------------       ------------

Net income (loss)                                             $    153,202       $   (655,124)      $    287,534       $   (840,769)
                                                                                 ============       ============       ============
                                                                                                                       ============

Net Income (loss) per common equivalent share                 $        .04                  $       $        .07       $       (.29)
                                                                                                                               (.21)
                                                              ============       ============       ============       ============

Weighted average common shares
   outstanding                                                   4,154,734          3,159,835          3,932,259          2,888,052
                                                              ============       ============       ============       ============
</TABLE>
                 See Notes to Consolidated Financial Statements.


                                       4
<PAGE>



================================================================================
                          UCI Medical Affiliates, Inc.
================================================================================
                      Consolidated Statements of Cash Flows

                                   (unaudited)
<TABLE>
<CAPTION>
                                                                       Six Months Ended March 31,
                                                                      1996                  1995
                                                                ------------------    ------------------
<S>                                                               <C>                  <C>    

OPERATING ACTIVITIES:
Net income (loss)                                                                              $   287,534              $  (840,769)
Adjustments to reconcile net income (loss) to net
   cash provided by  (used-in) operating activities:
      (Gain) loss on disposal of equipment                                                          (2,105)
                                                                                                                             (6,902)
      Provision for losses on accounts receivable                                                  367,097                  194,473
      Depreciation and amortization                                                                433,815                  232,293
Changes in operating assets and liabilities:
   (Increase) decrease in accounts receivable                                                   (1,088,157)                (626,376)
   (Increase) decrease in inventories                                                               (2,288)
                                                                                                                             (4,787)
   (Increase) decrease in prepaid expenses and other
      current assets                                                                              (145,348)                (150,587)
   Increase (decrease) in accounts payable and accrued
      expenses                                                                                    (654,614)
                                                                                                                             81,363
                                                                                               -----------              -----------

Cash provided by (used in) operating activities                                                   (804,066)              (1,121,292)
                                                                                               -----------              -----------

INVESTING ACTIVITIES:
Purchases of property and equipment                                                               (243,033)
                                                                                                                           (694,903)
Acquisitions of goodwill                                                                          (139,450)
                                                                                                                             (7,275)
(Increase) decrease in other assets                                                                (19,286)
                                                                                                                             10,886
                                                                                               -----------              -----------

Cash provided by (used in) investing activities                                                   (401,769)
                                                                                                                           (691,292)
                                                                                               -----------              -----------

FINANCING ACTIVITIES:
Issuance of common stock, net of redemptions                                                     1,500,492                1,000,000
Increase in long-term debt                                                                         725,000                  868,938
Payments on long-term debt                                                                        (922,010)
                                                                                                                           (266,640)
                                                                                               -----------              -----------

Cash provided by (used in) financing activities                                                  1,303,482                1,602,298
                                                                                               -----------              -----------

Increase (decrease) in cash and cash equivalents                                                    97,647
                                                                                                                           (210,286)
Cash and cash equivalents at beginning of period                                                    76,513                  210,286
                                                                                               -----------              -----------

Cash and cash equivalents at end of period                                                     $   174,160              $         0
                                                                                               ===========              ===========
</TABLE>
                 See Notes to Consolidated Financial Statements
                                       5
<PAGE>


                          UCI MEDICAL AFFILIATES, INC.

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)



BASIS OF PRESENTATION:

The accompanying  unaudited consolidated financial statements have been prepared
in  accordance  with  generally  accepted  accounting   principles  for  interim
financial information and with the instructions to Form 10-QSB and Article 10 of
Regulation S-X of the Securities and Exchange Commission.  Accordingly,  they do
not include all of the information and footnotes  required by generally accepted
accounting  principles  for  complete  financial  statements.  In the opinion of
management,  all  adjustments  (consisting  only of those of a normal  recurring
nature)  considered  necessary  for a  fair  presentation  have  been  included.
Operating  results for the six month or three month periods ended March 31, 1996
are not  necessarily  indicative  of the results  that may be  expected  for the
fiscal year ending  September 30, 1996.  For further  information,  refer to the
audited consolidated  financial statements and footnotes thereto included in the
Company's annual report on Form 10-KSB for the year ended September 30, 1995.

The consolidated  financial  statements of UCI Medical Affiliates,  Inc. include
the  accounts  of  UCI  Medical  Affiliates,  Inc.  ("UCI"),  its  wholly  owned
subsidiary,  UCI Medical Affiliates of SC, Inc. ("UCI-SC") and Doctor's Care, PA
("the P.A."),  collectively the "Company".  The financial statements of the P.A.
are consolidated with UCI because UCI-SC has unilateral  control over the assets
and operations of the P.A. and,  notwithstanding  the lack of technical majority
ownership, consolidation of the P.A. with UCI is necessary to present fairly the
financial position and results of operations of UCI. UCI-SC provides non-medical
management and  administrative  functions for 27 medical  centers,  operating as
Doctor's Care (the "Centers").  All medical services at the Centers are provided
by or under the  supervision  of the P.A.  The  medical  directors  operate  the
Centers under the financial and operational control of UCI-SC. However,  medical
supervision  of the centers is provided  solely by the P.A.  The P.A.  remits to
UCI-SC all medical service  revenues  generated by the Centers,  net of expenses
incurred by the P.A. This compensation is recorded in the accompanying financial
statements as revenue. Control of the P.A. is perpetual and other than temporary
because of the nature of this relationship and the management agreements between
the  entities.  The net  assets  of the P.A.  are not  material  for any  period
presented and intercompany accounts and transactions have been eliminated.


EARNINGS PER SHARE

The computation of income per common and common equivalent share is based on the
weighted average number of common shares  outstanding during the period plus (in
periods  in which  they have a  dilutive  effect)  the  effect of common  shares
issuable from stock options, using the treasury stock method.

                                       6

<PAGE>


                                     PART I

                              FINANCIAL INFORMATION

                                     ITEM 2



MANAGEMENT'S  DISCUSSION  AND  ANALYSIS OF  FINANCIAL  CONDITION  AND RESULTS OF
OPERATIONS

The following  discussion and analysis  provides  information  which the Company
believes  is  relevant  to an  assessment  and  understanding  of the  Company's
consolidated  results of operations  and financial  condition.  This  discussion
should be read in conjunction  with the  consolidated  financial  statements and
notes thereto.

Results of  Operations  For the Three Months Ended March 31, 1996 as Compared to
the Three Months Ended March 31, 1995

Revenues of $5,909,000 for the quarter ending March 31, 1996 reflect an increase
of 33% from those of the quarter ending March 31, 1995.

This  increase in revenue is  attributable  to a number of factors.  The Company
engaged in significant expansion,  increasing the number of medical centers from
23 to 27. This expansion included  Columbia's  Doctor's  Care-Cayce added in May
1995;  Myrtle  Beach's  Doctor's  Care-North  Myrtle  Beach opened in June 1995;
Greenville's  Doctor's  Care-Berea added in December 1995 and Columbia's Capitol
Internal Medicine opened in January 1996.  Additionally,  the Company acquired a
practice in North Myrtle Beach in March 1996 for $600,000  (consisting of 72,728
shares of common  stock and cash of  $300,000,  paid  $60,000 at closing and the
remainder in twenty-four  (24) monthly  installments)  which was merged into its
existing Doctor's Care - North Myrtle Beach center.  The Company also acquired a
practice in Columbia in March 1996 for $125,000  (consisting of 24,243 shares of
common stock and the assumption of $25,000 of trade accounts  payable) which was
merged into existing Columbia area centers.

The Company has increased its services provided to members of Health Maintenance
Organizations (HMOs). In such arrangements,  the Company, through Doctor's Care,
P.A., acts as the designated  primary  caregiver for members of the HMO who have
selected  Doctor's  Care as their  primary  care  provider.  The  Company  began
participating   in  an  HMO   operated  by  Companion   HealthCare   Corporation
("Companion"),  a wholly  owned  subsidiary  of Blue Cross Blue  Shield of South
Carolina in 1994.  The Company now acts as primary care  provider for four HMOs,
including  Companion.  While  HMOs do  not,  at this  time,  have a  significant
penetration into the South Carolina  market,  the Company believes that HMOs and
other managed care plans will experience a substantial  increase in market share
in the next few years, and the Company is therefore  positioning itself for that
possibility.

Increased  revenues also reflect the Company's  heightened focus on occupational
medicine and industrial health services. Focused marketing materials,  including
quarterly  newsletters for employers,  were developed to spotlight the Company's
services for industry. The Company also entered into an agreement with Companion
Property and Casualty Insurance Company, wherein the Company acts as the primary
care provider for injured  workers of firms insured through  Companion  Property
and Casualty  Insurance  Company.  Companion  Property  and  Casualty  Insurance
Company  is wholly  owned by Blue  Cross Blue  Shield of South  Carolina  and is
therefore   affiliated  with  Companion   HealthCare   Corporation,   a  primary
shareholder of the Company.

Patient encounters increased to 86,000 in the second quarter of fiscal 1996 from
75,000 in the second quarter of fiscal 1995.

An operating  margin of $563,000 was earned during the second  quarter of fiscal
1996 as  compared  to an  operating  loss of  $392,000  realized  for the second
quarter of fiscal 1995.  This  significant  improvement  is due, in part, to the
implementation  of significant  cost cutting  measures during the latter part of
the third  quarter of fiscal 1995,  including  very  substantial  and across the
board  reductions in personnel  costs and overtime and  aggressive  negotiations
with vendors to obtain more substantial discounts on medical supplies.
                                       7
<PAGE>

Depreciation  and  amortization  expense  increased  to  $229,000  in the second
quarter of fiscal 1996, up from  $171,000 in the second  quarter of fiscal 1995.
This increase  reflects higher  depreciation  expense as a result of significant
leasehold  improvements  and  equipment  upgrades  at a number of the  Company's
medical centers,  as well as an increase in amortization  expense related to the
intangible assets acquired from the Company's purchases of existing practices as
noted above.  Interest  expense  increased from $77,000 in the second quarter of
fiscal  1995 to $137,000 in the second  quarter of fiscal  1996  primarily  as a
result of the interest costs  associated with the  indebtedness  incurred in the
Company's purchase of these assets and centers.

For the Six Months  Ended March 31,  1996 as  Compared  to the Six Months  Ended
March 31, 1995

Revenues  of  $11,070,000  reflect an  increase  of 37% from the same  period in
fiscal 1995 and is attributable to the expansion, marketing and line of business
factors  discussed above.  Patient  encounters  increased to 165,000 for the six
months  ended  March 31, 1996 from  135,000  for the six months  ended March 31,
1995.

Financial Condition at March 31, 1996

Cash and cash equivalents increased by $98,000 during the six months ended March
31, 1996 mainly as a result of profitable  operations  and the issuance of stock
and debt.

Accounts receivable increased 31% during the period,  reflecting the addition of
three centers and the overall growth in patient visits to existing centers.

The increase in goodwill is  attributable to the purchases of the four practices
previously described.

The increase in the current  portion of long-term debt reflects  borrowings from
the Company's primary commercial bank.

Accounts payable  decreased  $644,000 during the first six months of fiscal 1996
to  $1,009,000  as a result of the  capital  infusions  during the  period  (see
Liquidity  and Capital  Resources  discussion  below).  Overall,  the  Company's
current assets exceeded its current liabilities by $860,000 at March 31, 1996.

Liquidity and Capital Resources

The Company requires  capital  principally to fund growth (acquire new centers),
for working capital needs and for the retirement of indebtedness.  The Company's
capital  requirements  and  working  capital  needs have been  funded  through a
combination  of external  financing  (including  bank debt and proceeds from the
sale of common stock to Companion HealthCare Corporation),  internally generated
funds and credit extended by suppliers.

Operating activities used $804,000 of cash during the first six months of fiscal
1996.  This  reflects  growth in the  Company's  accounts  receivable as well as
prepaid expenses and a decrease in accounts payable and accrued expenses.

Investing  activities  used  $402,000  of cash during the quarter as a result of
expansion  efforts.  Continued  growth is  anticipated  during the  remainder of
fiscal 1996.

On November 3, 1995, the Company,  through a private  placement,  issued 218,180
shares of common  stock at $2.75 per share to Companion  HealthCare  Corporation
and received  $599,995 in cash.  On December 15,  1995,  the Company,  through a
private  placement,  issued another  218,180 shares of common stock at $2.75 per
share to Companion HealthCare  Corporation and received another $599,995 in cash
and on March 1, 1996, the Company,  through a private placement,  issued 109,091
shares of common  stock at $2.75 per share to Companion  HealthCare  Corporation
and received $300,000 in cash.

In March 1996, the Company paid out its line of credit for $475,000 and borrowed
another $725,000 from the same primary commercial bank.

                                        8


<PAGE>

Subsequent Events

On April 12, 1996,  the Company  acquired  substantially  all of the assets of a
medical  practice in  Greenville,  South  Carolina for $541,000  (consisting  of
125,187  shares of common stock,  the  assumption  of $27,000 of trade  accounts
payable and cash of $76,000,  paid $6,300 at closing and the remainder  over the
next eleven  months) and merged this practice into its existing  Doctor's Care -
Pelham center located in Greenville.


                                       9


<PAGE>


                                     PART II

                                OTHER INFORMATION



Item 1            LEGAL PROCEEDINGS

                  The  Company is not a party to any  pending  litigation  other
                  than  routine  litigation  incidental  to the business or that
                  which is immaterial in amount of damages sought.


Item 2            CHANGES IN SECURITIES

                  This item is not applicable.


Item 3            DEFAULTS UPON SENIOR SECURITIES

                  This item is not applicable.


Item 4            SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

                  This item is not applicable.


Item 5            OTHER INFORMATION

                  This item is not applicable.


Item 6            EXHIBITS AND REPORTS ON FORM 8-K

                  The  Company  filed a Form  8-K  during  January  1996,  which
                  announced  that it had  received  approval  for trading on the
                  NASDAQ  Small Cap  Market.  Effective  January  2,  1996,  the
                  Company began trading under the symbol UCIA.

                  The Company  filed a Form 8-K during  January 1996 to announce
                  the  acquisition  of its  Doctor's  Care  -  Berea  center  in
                  Greenville, South Carolina.

                  The Company filed a Form 8-K during March 1996 to announce the
                  acquisition  of a North Myrtle  Beach and a Columbia  practice
                  which  were  merged  into  existing  North  Myrtle  Beach  and
                  Columbia centers.



<PAGE>


                                    SIGNATURE



Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


UCI Medical Affiliates, Inc.
         (Registrant)



/S/ M.F. MCFARLAND, III, M.D.                     /S/ JERRY F. WELLS, JR.
Marion F. McFarland, III, M.D.                    Jerry F. Wells, Jr.
President, Chief Executive Officer,               Vice President of Finance and
and Chairman of the Board                         Chief Financial Officer




Date:  April 26, 1996


                                       11



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission